Valuation: Neogen Corporation

Market Cap 2.05B 1.8B 1.67B 1.53B 2.88B 197B 2.93B 19.85B 7.75B 96.87B 7.68B 7.52B 335B P/E 2026 *
-141x
P/E 2027 * -38.4x
Enterprise Value 2.05B 1.8B 1.67B 1.53B 2.88B 197B 2.93B 19.85B 7.75B 96.87B 7.68B 7.52B 335B EV / Sales 2026 *
2.39x
EV / Sales 2027 * 2.41x
Free-Float
99.05%
Yield 2026 *
-
Yield 2027 * -
1 day-2.19%
1 week-8.47%
Current month+4.56%
1 month-1.88%
3 months-1.47%
6 months-6.09%
Current year+34.48%
1 week 9.39
Extreme 9.39
10.12
1 month 8.68
Extreme 8.685
10.43
Current year 6.89
Extreme 6.89
11.42
1 year 4.56
Extreme 4.5601
11.42
3 years 3.87
Extreme 3.8701
24.1
5 years 3.87
Extreme 3.8701
47.8
10 years 3.87
Extreme 3.8701
48.85
Manager TitleAgeSince
Chief Executive Officer 50 11/08/2025
Director of Finance/CFO 56 03/11/2025
Compliance Officer 61 08/04/2026
Director TitleAgeSince
Director/Board Member 65 01/01/2014
Chairman 70 10/04/2020
Director/Board Member 58 08/10/2020
Date Insider Type Main position Quantity % Market Cap.
3/6/26 Tax

Controller/Auditor

-2,553 0.0012%
18/5/26 Fiscal year

Former Chief Legal Officer

80,607 0.0370%
4/5/26 Fiscal year

Controller/Auditor

10,684 0.0049%
Change 5-day change 1-year change 3-year change Capi.($)
-2.19%-8.47%+80.08%-58.37% 2.05B
+2.29%+2.36%-18.56%-9.66% 180B
+1.46%+0.01%-10.47%-7.95% 107B
+1.58%+0.65%+6.73%+65.09% 60.29B
+1.06%-2.51%+27.20%+56.09% 50.19B
+2.22%-1.14%-15.63%-44.71% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-19.61%-45.26% 27.61B
-7.67%-8.39%+24.55%-13.50% 23.1B
+1.63%-1.73%-7.11%-7.67% 20.86B
Average +0.48%-2.86%+7.46%-7.33% 54.6B
Weighted average by Cap. +1.47%-0.43%-6.44%+0.76%

Financials

2026 *2027 *
Net sales 857M 753M 700M 643M 1.21B 82.57B 1.23B 8.32B 3.25B 40.6B 3.22B 3.15B 140B 849M 746M 694M 636M 1.2B 81.77B 1.21B 8.24B 3.22B 40.2B 3.19B 3.12B 139B
Net income -15.08M -13.25M -12.32M -11.31M -21.24M -1.45B -21.57M -146M -57.16M -714M -56.63M -55.41M -2.47B -53.35M -46.86M -43.58M -39.99M -75.13M -5.14B -76.29M -517M -202M -2.53B -200M -196M -8.73B
Net Debt - -
Logo Neogen Corporation
Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.
Employees
2,974
Date Price Change Volume
24/07/26 USD 9.400 -2.19% 1,190,308
23/07/26 USD 9.610 -2.24% 1,515,044
22/07/26 USD 9.830 -1.01% 1,184,228
21/07/26 USD 9.930 -0.80% 1,605,318
20/07/26 USD 10.01 -2.53% 1,029,549
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
9.400USD
Average target price
12.00USD
Spread / Average Target
+27.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NEOG Stock